Follow The Filings

OSUR Orasure Technologies Inc.

Health Care, filed as ORASURE TECHNOLOGIES INC (COM), Equity As of 2026 Q3 among managers we track Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q2, sold by 1

  • 1 Owner
  • Max 0.1%
  • $336K
  • 1 reduce

In 2026 Q3 Murphy Pohlad trimmed Orasure Technologies.

Who owns this now

Largest portfolio weights among holders, up to 0.1% (Murphy Pohlad, Murphy Pohlad Asset Management). Not free-float ownership.

  1. Murphy Pohlad Reduce 0.12%

Who owns OSUR

Sorted by value, long equity only, as of 2026 Q3.

History
Murphy Pohlad, Murphy Pohlad Asset Management 0.12%, was 0.17% Reduce −19.4% 85,667 $336K History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by OSUR's executives, directors and 10% owners in the last 12 months, from their Form 4s

All OSUR insider trades
  • $551K bought by 4 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Steven Kyle Boyd Director
    Buy
    $225K 75,000 shares at $3.00 +195% to stake
    Traded May 12–14 Filed May 14
    ↗
  2. Kenneth J McGrath CFO
    Buy
    $95K 32,300 shares at $2.93 +5.8% to stake
    Traded Mar 20 Filed Mar 23
    ↗
  3. Manner Carrie Eglinton CEO
    Buy
    $95K 32,300 shares at $2.93 +1.5% to stake
    Traded Mar 20 Filed Mar 23
    ↗
  4. Kenneth J McGrath CFO
    Buy
    $66K 22,021 shares at $3.00 +4.1% to stake
    Traded Mar 13 Filed Mar 16
    ↗
  5. Manner Carrie Eglinton CEO
    Buy
    $66K 22,022 shares at $3.00 +1% to stake
    Traded Mar 13 Filed Mar 16
    ↗
  6. Nancy J Gagliano Director
    Buy
    $4,982 2,100 shares at $2.37 +1.3% to stake
    Traded Nov 28, 2025 Filed Dec 2, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 18 stock grants and 11 share withholdings for taxes.

SEC filings

Recent issuer filings from EDGAR, 21 shown.

Filed Form Detail Links
SCHEDULE 13D — Filing Doc
SCHEDULE 13G — Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 8.01 Filing Doc
8-K 5.02,5.03,5.07,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
DEF 14A Filing Doc
SCHEDULE 13D/A — Filing Doc
8-K 1.01,5.02,7.01,9.01 Filing Doc
DEFA14A Filing Doc
DEFA14A Filing Doc
SCHEDULE 13G — Filing Doc
8-K 7.01,9.01 Filing Doc
DEFA14A Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13D/A — Filing Doc
DEFA14A Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $405.47M $185.83M $115.02M
Gross profit $171.65M $79.39M $48.2M
Gross margin * 42.3% 42.7% 41.9%
Net income $53.66M -$19.5M -$68.73M
Net margin * 13.2% -10.5% -59.8%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $386.46M $333.22M $261.91M
Total non-current assets $96.39M $146.44M $141.26M
Total assets $482.84M $479.66M $403.17M
Total current liabilities $39.54M $33.48M $39.8M
Total non-current liabilities $12.64M $35.84M $22.55M
Total equity $430.67M $410.34M $340.83M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $141.58M $27.37M -$49.02M
Cash from investing $66.15M -$39.03M -$6.81M
Cash from financing -$3.02M -$4.18M -$16.94M
Net change in cash $206.43M -$22.64M -$68.48M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.